HCV is considered very hardy; a recent study
found that cell culture–derived HCV can remain infectious
on surfaces up to six weeks, suggesting that
accidental contact with contaminated surfaces may be
a source of health care–associated transmission.22 In
light of these findings, health care providers would be
well advised to avoid percutaneous exposure to infected
blood. Currently there is no vaccine for HCV.